In a groundbreaking clinical trial, the active ingredient in the popular weight loss medication Zepbound, known as tirzepatide, has been shown to reduce the risk of developing type 2 diabetes
Continue readingTirzepatide Dramatically Lowers Type 2 Diabetes Risk 94%
In light of recent FDA alerts regarding dosing errors associated with compounded injectable semaglutide products, our clinic has reaffirmed our commitment to patient safety, efficacy, and adherence to medical standards
Continue readingReflection on the Importance of Pre-Filling Syringes at Our Clinic
The rise of “Ozempic babies” has garnered attention nationwide, spotlighting the unexpected link between GLP-1 medications, weight loss, and enhanced fertility. Originally developed for diabetes management, GLP-1 receptor agonists (GLP-1 RAs) like Ozempic, Wegovy, Mounjaro, and Zepbound have also shown surprising benefits, including significant weight loss, improved cardiovascular and kidney health, and now, a possible boost in fertility. …
Losing weight after pregnancy can be challenging, but GLP-1 medications may offer new moms a way to regain their pre-pregnancy body and improve overall health. These medications help regulate blood
Continue readingLosing Weight After Pregnancy: How GLP-1 Medications Can Help New Moms
Mounjaro (tirzepatide) and Ozempic (semaglutide) – What’s the difference? …
Continue readingMounjaro (tirzepatide) and Ozempic (semaglutide) – What’s the difference?
The SURMOUNT-4 phase 3 clinical trial, led by researchers at Weill Cornell Medicine and NewYork-Presbyterian, investigated the effectiveness of anti-obesity drugs, particularly tirzepatide, in maintaining weight loss over the long